Market Place
Sourcing Support
Tr1X gets $8M CIRM grant for TRX103 Phase 1/2a trial
04 Apr 2025 //
GLOBENEWSWIRE
Tr1X Appoints David de Vries CEO, Effective June 1
28 Mar 2025 //
GLOBENEWSWIRE
Tr1X Receives FDA Clearance For TRX103 IND In Crohn`s Disease
07 Aug 2024 //
GLOBENEWSWIRE
Tr1X Doses First Patient In GvHD Trial Of TRX103 Tr1 Cell Therapy
10 Jul 2024 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.